Sutro Biopharma

$17.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.60 (+3.64%) Today

+$0.24 (+1.40%) As of 5:00 PM EST after-hours

Why Robinhood?

You can buy or sell STRO and other stocks, options, and ETFs commission-free!

About STRO

Sutro Biopharma Inc. engages in the drug discovery, development, and manufacturing of pharmaceutical products. It focuses on next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA. The listed name for STRO is Sutro Biopharma, Inc. Common Stock.

CEO

William J. Newell

Employees

168

Headquarters

South San Francisco, California

Founded

2003

Market Cap

660.13M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

336.07K

High Today

$17.38

Low Today

$16.56

Open Price

$16.61

Volume

585.99K

52 Week High

$19.19

52 Week Low

$6.00

Collections

Analyst Ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

STRO Earnings

-$0.84

-$0.41

$0.02

$0.45

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 16, Pre-Market